Drug Delivery Roundtable: Whitehead and Langer

1

Introduction

00:00 • 2min

2

The Future of Drug Delivery Technologies

02:18 • 2min

3

RNA Nanoparticles - How Do We Get Them to the Cells That We Need to Target?

04:07 • 3min

4

What Kind of Particle Nanoparticles Are in Clinical Use?

06:44 • 2min

5

Anti-Pec Nanoparticles - What Are the Strategies to Avoid?

09:05 • 5min

6

Can Nanoparticles Really Be Used for Drug Delivery?

13:37 • 2min

7

The Next Step in the Life of a Therapeutic Nanoparticle

15:19 • 2min

8

RES and the Blood Brain Barrier

17:19 • 4min

9

Is Nanotechnology a Good Approach to Targeting Cancer Cells?

20:49 • 3min

10

Is Nanoparticle Delivery a Last Barrier to Endocytosis?

23:21 • 2min

11

How to Increase Endosomal Escape?

25:08 • 3min

12

Can Nanoparticles Take Advantage of Physical Environment Changes?

27:43 • 2min

13

Nanoparticle Delivery - The Holy Grail of the Delivery

30:04 • 2min

14

Active Targeting for Non-Viral Delivery Systems

31:46 • 3min

15

Is Detargeting a Chemotherapeutic Drug a Problem?

34:21 • 3min

16

Getting a Head to Head Comparison of Nanoparticles

37:32 • 2min

17

What Will the Future Bring?

39:49 • 4min